A patient with advanced cutaneous squamous cell carcinoma achieved a near complete response from immunotherapy.
Two cases — both tremendously different in their level of complexity — illustrate the core principles of nasal reconstruction.
Study examines appropriate therapy sequence for patients with BRAFV600-mutant melanoma
Cleveland Clinic researchers aim to assess the appropriate timing and role of immunotherapies for treating advanced melanoma
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic began offering shared medical appointments for early stage post-extraction melanoma patients in August hoping to change self-care behaviors and prevent recurrence of the disease.
A Cleveland Clinic-led trial uncovered a novel signaling pathway in skin cancer that might be an important therapeutic target for certain cancers.
Marc Ernstoff, MD, the recently appointed director of Cleveland Clinic’s Melanoma Program, cites a strong research base and advanced approaches to diagnoses and therapy as the enterprise’s distinguishing characteristics.